ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical models
Amanda Hanson, Christopher J. Harvey(University of Kansas Medical Center)
Cited by 40
Related Papers
No related papers found
Powered by citation graph analysis